Consequently, further studies with a much larger sample size and unified methodological approach are needed to better understand the reasons behind the varying levels of SOD and catalase that have been reported in β-thalassemia and SCD patients. This evidence concerns the gene SOD1 and Schnyder corneal dystrophy.